Nuvation Bio
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New York, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1500 Broadway Ste 1401, New York, New Yo...Phone Number
(332) 208-6102Website
www.nuvationbio.comRevenue
$169.9 MillionStock Symbol
NUVBIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Nuvation Bio
Nuvation Bio is a global biopharmaceutical company focused on treating patients with the most difficult-to-treat cancers for which conventional therapies have failed. Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel product candidates.Explore more
Nuvation Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvation Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nuvation Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Nuvation Bio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Nuvation Bio
Funding: Get notified immidiatlly once Nuvation Bio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nuvation Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nuvation Bio recently announced quarterly report
Product Launch: Get notified when Nuvation Bio launches new products
Website visits: Recent activity has been detected on your website
Check out if Nuvation Bio is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nuvation Bio
Compare insights from companies similar to Nuvation Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuvation Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuvation Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuvation Bio.
Nuvation Bio financials insights
Gather financial insights about Nuvation Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$275M
2025
Other Financing Round
$250M
Nuvation Bio Tech Stack
A closer look at the technologies used by Nuvation Bio
See more technologies
Most Recent Scoops
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Open Position
Nuvation Bio News & Media
Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
Designation offers pathway to expedite regulatory review, pending positive data, and reinforces safusidenib's potential to address significant medical needs for patients with IDH1-mutant glioma Pivotal Phase 3 SIGMA study enrollment underway NEW YORK, Aug. 20, 2026 /PRNewswire/ --...Nuvation Bio Q2 Earnings Call Highlights
Nuvation Bio (NYSE:NUVB) reported second-quarter total revenue of $31.7 million, including $23.2 million in net U.S. product revenue from IBTROZI, as the company said use of the ROS1-targeted lung cancer therapy continued to shift toward first-line patients. IBTROZI revenue increased 25% from the fNuvation Bio Inc. (NUVB) Q2 2026 Earnings Call Transcript
Nuvation Bio Inc. (NUVB) Q2 2026 Earnings Call August 6, 2026 8:00 AM EDTCompany ParticipantsRobert DeVita - Vice President of Corporate Development &...Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Achieved $31.7 million in second quarter 2026 total revenue, including $23.2 million in net product revenue for IBTROZI® (taletrectinib) IBTROZI is the most prescribed ROS1 TKI in in both first-line and overall new patient starts in 2026 based on IQVIA claims from first five months of the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nuvation Bio
Sign Up For FreeTo access detailed company insights
Nuvation Bio is a global biopharmaceutical company focused on treating patients with the most difficult-to-treat cancers for which conventional therapies have failed. Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel product candidates.... Read More
